CB1 cannabinoid receptor expression is regulated by glucose and feeding in rat pancreatic islets

Regulatory Peptides

Volumn 163, Issue 1-3, 2010, Pages 81-87

  Vilches Flores, Alonso ^a   Delgado Buenrostro, Norma Laura ^a   Navarrete Vázquez, Gabriel ^b   Villalobos Molina, Rafael ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

Author keywords

Endocannabinoid system; Glucose; Pancreatic islets; Rimonabant analog

Indexed keywords

1(4 CHLOROPHENYL) 2 (2,4 DICHLOROPHENYL) N (1 PIPERIDINYL) 1 H BENZIMIDAZOLE 5 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; GLUCAGON; GLUCOKINASE; GLUCOSE; INSULIN; MESSENGER RNA; RIMONABANT; RIMONABANT DERIVATIVE; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; GENE EXPRESSION; GLUCOSE INTAKE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; EATING; FASTING; GLUCOSE; ISLETS OF LANGERHANS; MALE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS; RATTUS NORVEGICUS;

EID: 77953915924     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.04.013     Document Type: Article

References (33)

1. Pagotto U., Marsicano G., Cota D., Lutz B., Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocrinol Rev 2006, 27:73-100.
2. Kunos G. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?. Am J Med 2007, 120:S18-S24. discussion S24.
3. Di Marzo V. CB(1) receptor antagonism: biological basis for metabolic effects. Drug Discov Today 2008, 13:1026-1041.
4. 2+) signals and insulin secretion in pancreatic β-cell. Cell Calcium 2006, 39:155-162.
5. 2+ oscillation in islet β-cells via CB1 receptors. Regul Pept 2008, 145:49-53.
6. De Petrocellis L., Marini P., Matias I., Moriello A.S., Starowicz K., Cristino L., Nigam S., Di Marzo V. Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells. Exp Cell Res 2007, 313(14):2993-3004.
7. Matias I., Gonthier M.P., Orlando P., Martiadis V., De Petrocellis L., Cervino C., Petrosino S., Hoareau L., Festy F., Pasquali R., Roche R., Maj M., Pagotto U., Monteleone P., Di Marzo V. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 2006, 91:3171-3180.
8. Bermúdez-Silva F.J., Suárez J., Baixeras E., Cobo N., Bautista D., Cuesta-Muñoz A.L., Fuentes E., Juan-Pico P., Castro M.J., Milman G., Mechoulam R., Nadal A., Rodríguez de Fonseca F. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008, 51(3):476-487.
9. Duvivier V.F., Delafoy-Plasse L., Delion V., Lechevalier P., Le Bail J.C., Guillot E., Pruniaux M.P., Galzin A.M. Beneficial effect of a chronic treatment with rimonabant on pancreatic function and beta-cell morphology in Zucker fatty rats. Eur J Pharmacol 2009, 616:314-320.
10. Starowicz K.M., Cristino L., Matias I., Capasso R., Racioppi A., Izzo A.A., Di Marzo V. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity 2008, 16(3):553-565.
11. Juan-Pico P, Ropero AB, Tuduri E, Quesada I, Fuentes E, Bermudez-Silva FJ, Rodriguez de Fonseca F, Nadal A. Regulation of glucose-induced [Ca2+] signals by cannabinoid CB1 and CB2 receptors in pancreatic α- and δ-cells within intact islets of Langerhans. Obes Metab 2009;5:20-8.
12. Bermúdez-Silva F.J., Sanchez-Vera I., Suárez J., Serrano A., Fuentes E., Juan-Pico P., Nadal A., Rodríguez de Fonseca F. Role of cannabinoid CB2 receptors in glucose homeostasis in rats. Eur J Pharmacol 2007, 565:207-211.
13. Laychock S.G., Hoffman J.M., Meisel E., Bilgin S. Pancreatic islet arachidonic acid turnover and metabolism and insulin release in response to delta-9-tetrahydrocannabinol. Biochem Pharmacol 1986, 35:2003-2008.
14. Tharp W.G., Lee Y.H., Maple R.L., Pratley R.E. The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochem Biophys Res Commun 2008, 372:595-600.
15. Getty-Kaushik L., Richard A.M., Deeney J.T., Krawczyk S., Shirihai O., Corkey B.E. The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets. Obesity 2009, 17(10):1856-1860.
16. Kirkham T.C., Williams C.M., Fezza F., Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 2002, 136:550-557.
17. Matias I., Gonthier M.P., Petrosino S., Docimo L., Capasso R., Hoareau L., Monteleone P., Roche R., Izzo A.A., Di Marzo V. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br J Pharmacol 2007, 152:676-690.
18. Gómez R., Navarro M., Ferrer B., Trigo J.M., Bilbao A., Del Arco I., Cippitelli A., Nava F., Piomelli D., Rodríguez de Fonseca F. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. J Neurosci 2002, 22(21):9612-9617.
19. Izzo A.A., Piscitelli F., Capasso R., Aviello G., Romano B., Borrelli F., Petrosino S., Di Marzo V. Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. Br J Pharmacol 2009, 158(2):451-461.
20. Di Marzo V., Goparaju S.K., Wang L., Liu J., Bátkai S., Járai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
21. Di Marzo V., Capasso R., Matias I., Aviello G., Petrosino S., Borrelli F., Romano B., Orlando P., Capasso F., Izzo A.A. The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. Br J Pharmacol 2008, 153(6):1272-1280.
22. Cottone E., Guastalla A., Pomatto V., Campantico E., Di Marzo V., Franzoni M. Goldfish CB1 mRNA expression is affected by fasting and anandamide administration. NeuroReport 2009, 20:595-599.
23. Jelsing J., Larsen P.J., Vrang N. The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion. Neurosci Lett 2009, 463:125-129.
24. Omori K., Mitsuhashi M., Todorov I., Rawson J., Shiang K.D., Kandeel F., Mullen Y. Microassay for glucose-induced preproinsulin mRNA expression to assess islet functional potency for islet transplantation. Transplantation 2010, 89(2):146-154.
25. Moede T., Leibiger B., Berggren P.O., Leibiger I.B. Online monitoring of stimulus-induced gene expression in pancreatic beta-cells. Diabetes 2001, 50(Suppl 1):S15-S19.
26. Vilches-Flores A., Tovar A.R., Marin-Hernandez A., Rojas-Ochoa A., Fernandez-Mejia C. Biotin increases glucokinase expression via soluble guanylate cyclase/protein kinase G, adenosine triphosphate production and autocrine action of insulin in pancreatic rat islets. J Nutr Biochem 2010, 21(7):606-612.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(t)] method. Methods 2001, 25:402-408.
28. Bensaid M., Gary-Bobo M., Esclangon A., Maffrand J.P., Le Fur G., Oury-Donat F., Soubrié P. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003, 63:908-914.
29. Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Péleraux A., Pénarier G., Soubrié P., Le Fur G., Galiègue S., Casellas P. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 2005, 19:1567-1569.
30. Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Bátkai S., Harvey-White J., Mackie K., Offertáler L., Wang L., Kunos G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005, 115:1298-1305.
31. Ahlgren U., Jonsson J., Jonsson L., Simu K., Edlund H. Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998, 12:1763-1768.
32. Matschinsky F.M. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes 2002, 51:S394-S404.
33. Lauckner J.E., Jensen J.B., Chen H.Y., Lu H.C., Hille B., Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci USA 2008, 105(7):2699-2704.